Aclaris Therapeutics, Inc. (ACRS)
3.44
-0.06
(-1.71%)
USD |
NASDAQ |
Nov 20, 16:00
3.445
0.00 (0.00%)
After-Hours: 20:00
Aclaris Therapeutics Price : 3.44 for Nov. 20, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2026 | 3.44 | 3.545 | 3.40 | 3.44 | 2.188M |
| Nov 19, 2026 | 3.53 | 3.62 | 3.44 | 3.50 | 1.894M |
| Nov 18, 2026 | 3.38 | 3.52 | 3.255 | 3.50 | 2.941M |
| Nov 17, 2026 | 3.47 | 3.559 | 3.32 | 3.38 | 3.125M |
| Nov 16, 2026 | 3.38 | 3.70 | 3.28 | 3.605 | 9.950M |
| Nov 13, 2026 | 3.98 | 3.99 | 3.775 | 3.92 | 1.147M |
| Nov 12, 2026 | 4.29 | 4.33 | 3.995 | 4.00 | 1.957M |
| Nov 11, 2026 | 4.14 | 4.40 | 4.08 | 4.34 | 1.981M |
| Nov 10, 2026 | 4.19 | 4.295 | 4.065 | 4.15 | 1.397M |
| Nov 09, 2026 | 3.95 | 4.295 | 3.85 | 4.24 | 2.028M |
| Nov 06, 2026 | 3.62 | 3.975 | 3.610 | 3.90 | 3.526M |
| Nov 05, 2026 | 3.71 | 3.72 | 3.45 | 3.61 | 2.330M |
| Nov 04, 2026 | 3.81 | 3.88 | 3.63 | 3.68 | 2.045M |
| Nov 03, 2026 | 3.83 | 3.94 | 3.665 | 3.74 | 1.866M |
| Nov 02, 2026 | 4.085 | 4.085 | 3.765 | 3.80 | 1.645M |
| Oct 30, 2026 | 4.00 | 4.07 | 3.87 | 3.97 | 1.880M |
| Oct 29, 2026 | 4.01 | 4.079 | 3.96 | 3.99 | 1.459M |
| Oct 28, 2026 | 3.70 | 3.975 | 3.66 | 3.96 | 3.879M |
| Oct 27, 2026 | 3.98 | 4.00 | 3.44 | 3.79 | 7.986M |
| Oct 26, 2026 | 3.78 | 3.85 | 3.715 | 3.79 | 1.573M |
| Oct 23, 2026 | 3.81 | 3.845 | 3.681 | 3.75 | 2.290M |
| Oct 22, 2026 | 3.77 | 3.98 | 3.735 | 3.83 | 2.799M |
| Oct 21, 2026 | 3.74 | 3.97 | 3.69 | 3.81 | 2.663M |
| Oct 20, 2026 | 3.41 | 3.81 | 3.37 | 3.77 | 3.499M |
| Oct 19, 2026 | 3.28 | 3.50 | 3.255 | 3.48 | 1.747M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ANI Pharmaceuticals, Inc. | 68.55 |
| Corcept Therapeutics, Inc. | 63.62 |
| Veru, Inc. | 1.94 |
| Johnson & Johnson | 270.47 |
| Eli Lilly & Co. | 1347.11 |
Price Related Metrics
| PS Ratio | 73.04 |
| Price to Book Value | 3.111 |
| Earnings Yield | -17.15% |
| Market Cap | 518.84M |